Purchase Order 75N90018P00512
Award Date 6/7/18
Potential Completion Date 6/6/19
Potential Value $3.5K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the National Institutes of Health (NIH) Clinical Center to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The $2,387.15 firm fixed-price purchase order is for the supply of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as the radiopharmaceutical therapy Xofigo (radium-223 dichloride) for prostate cancer treatment. These critical medical...
- This $22,829.59 firm fixed-price federal contract was awarded by the National Institutes of Health (NIH) Clinical Center to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of a variety of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies such as Xofigo (radium-223 dichloride) for prostate cancer treatment. These products...
- This federal contract award, with ID 75N90018P00478, was issued by the National Institutes of Health (NIH) Clinical Center to Cardinal Health 414, LLC, a subsidiary of the global healthcare services company Cardinal Health, Inc. The $24,587.55 firm-fixed-price purchase order is for the delivery of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, to support nuclear medicine, oncology, and diagnostic...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract, valued at $3,835.00, is a firm fixed-price purchase order for various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67. The products will be used to support nuclear...
- This federal contract award was made by the National Institutes of Health (NIH) Clinical Center to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The $22,659.68 firm fixed-price purchase order is for the delivery of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, and others, to support nuclear medicine, oncology, and diagnostic imaging services at NIH facilities. Cardinal Health 414 is a major supplier of radiopharmaceuticals and related...
- This is a $22,093.85 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, to support nuclear medicine, oncology, and diagnostic imaging services at NIH facilities. Cardinal Health 414 provides both scheduled...
- This is a $22,733.47 firm fixed-price purchase order awarded to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., by the National Institutes of Health (NIH) Clinical Center. The contract is for the supply of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, to support nuclear medicine, oncology, and diagnostic imaging services at NIH research centers. Cardinal Health 414 also provides...
- This federal contract award, with an ID of 75N90019P00314, is a purchase order for $20,437.06 awarded to Cardinal Health 414, LLC, a subsidiary of the global healthcare services company Cardinal Health, Inc. The contract is for the supply of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies like Xofigo (radium-223 dichloride), to the National Institutes of Health...
- This federal contract award was made by the National Institutes of Health (NIH) Clinical Center to Cardinal Health 414, LLC, a subsidiary of the larger Cardinal Health, Inc. corporation. The $15,108.57 firm fixed-price purchase order is for the supply of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies like Xofigo (radium-223 dichloride) for prostate cancer...
- This federal contract award, valued at $405,154.73, was issued by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies such as Xofigo (radium-223 dichloride) for prostate cancer treatment. These products are delivered to VA medical...